Broad-Based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention

Journal of Alzheimer's Disease

Volumn 32, Issue 1, 2012, Pages 217-232

  Wolf, Andrew B ^a,b,i   Braden, B Blair ^b,i   Bimonte Nelson, Heather ^b,i   Kusne, Yael ^a,b,i   Young, Nicole ^a,b,i   Engler Chiurazzi, Elizabeth ^b,i   Garcia, Alexandra N ^b,i   Walker, Douglas G ^c,i   Moses, Guna S D ^c,d,i   Tran, Hung ^c,i   Laferla, Frank ^e   Lue, Lihfen ^c,i   Emerson Lombardo, Nancy ^f,g   Valla, Jon ^a,h,i  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

^d GRAND CANYON UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h MIDWESTERN UNIVERSITY   (United States)

ⁱ ARIZONA ALZHEIMER S CONSORTIUM   (United States)

Author keywords

Biomarkers; cytochrome c oxidase (Complex IV); diet therapy; memory; sex; transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CYTOCHROME C OXIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUCOSE DERIVATIVE; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PHYTONUTRIENT; PRIORITY JOURNAL; SEX DIFFERENCE; TASK PERFORMANCE;

EID: 84867545294     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120478     Document Type: Article

References (46)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International (2005) Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117.
2. Morris MC (2009) The role of nutrition in Alzheimer's disease: Epidemiological evidence. Eur J Neurol 16, 1-7.
3. Kamphuis PJGH, Scheltens P (2010) Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 20, 765-775.
4. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D (2003) Blueberry supplementation enhances signaling and prevent behavioral deficits in an Alzheimer's disease model. Nutr Neurosci 6, 153-162.
5. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid- oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280, 5892-5901.
6. Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT (2009) Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr 139, 1987-1993.
7. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25, 8807-8814.
8. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S,Vassar R, SegalD, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces -amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. Plos One 6, e16564.
9. Wang J, Ho L, Zhao W, Ono K, Rosenweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent A- oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28, 6388-6992.
10. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L, LaFerla FM (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid- and tau pathology via a mechanism involving Presenilin 1 levels. J Neurosci 27, 4385-4395.
11. Grimm MOW, Kuchnbecker J, Grosgen S, Burg VK, Hunsdorfer B, Rothhaar TL, Friess P, de Wilde MC, Broersen LM, Penke B, Peter M, Vigh L, Grimm HS, Hartmann T (2011) Docosahexaenoic acid reduces amyloid- production via multiple pleiotropic mechanisms. J Biol Chem 286, 14028-14039.
12. LimGP, Calon F, MoriharaT,Yang F,Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole GM (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic aicd reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032-3040.
13. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lutjohann D, Hartmann T, TanilaH(2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23, 563-572.
14. Arsenault D, Julien C, Tremblay C, Calon F (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. Plos One 6, e17397.
15. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645.
16. Parachikova A, Green KN, Hendrix C, LaFerla FM (2010) Formulation of a medical food cocktail for Alzheimer's disease: Beneficial effects on cognition and neuropathology in a mouse model of the disease. Plos One 5, e14015.
17. Lee S, Lemere CA, Frost JL, Shea TB (2011) Dietary supplementation with S-adenosyl methionine delayed amyloid- and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28, 1-9.
18. Fuso A, Scarpa S (2011) One-carbon metabolism and Alzheimer's disease: Is it all a methylation matter? Neurobiol Aging 32, 1192-1195.
19. Emerson Lombardo NB, Volicer L, Martin A, Wu B, Zhang XW. (2005) Memory preservation diet to reduce risk and slow progression of Alzheimer's disease. In Research and Practice in Alzheimer's Disease and Cognitive Decline, Vellas B, Grundman M, Feldman, H, Fitten LJ, Winblad B, Eds. Springer, New York, pp. 138-159.
20. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular amyloid-. Neuron 39, 409-421.
21. Capodice JL, Gorroochurn P, Cammack AS, Goluboff E, McKiernan JM, Benson MC, Stone BA, Katz AE (2009) Zyflamend in men with high-grade prostatic intraepithelial neoplasia: Results of a phase I clinical trial. J Soc Integr Oncol 7, 43-51.
22. Freund-LeviY, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study:Arandomized double-blind trial. Arch Neurol 63, 1402-1408.
23. Reiman EM, Uecker A, Gonzalez-Lima F, Minear D, Chen K, Callaway NL, Berndt JD, Games D (2000) Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 11, 987-991.
24. Valla J, Schneider L, Reiman EM (2006) Age- and transgenerelated changes in regional cerebral metabolism in PSAPP mice. Brain Res 1116, 194-200.
25. Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J (2010) Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347, 179-185.
26. Valla J, Gonzalez-Lima F, Reiman EM (2008) FDG autoradiography reveals developmental and pathological effects of mutant amyloid inPDAPPtransgenic mice. Int JDev Neurosci 26, 253-258.
27. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the -4 allele for apolipoprotein E. New Engl J Med 334, 752-758.
28. Minoshima S, Foster NL, Kuhl DE (1994) Posterior cingulated cortex in Alzheimer's disease. Lancet 344, 895.
29. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A 101, 284-289.
30. Valla J, Schneider LE, Niedzielko T, Coon KD, Caselli RJ, Sabbagh MN, Ahern GL, Baxter L, Alexander G,Walker DG, Reiman EM (2006) Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6, 323-330.
31. Valla J, Berndt JD, Gonzalez-Lima F (2001) Energy hypometabolism in posterior cingulated cortex of Alzheimer's patients: Superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21, 4923-4930.
32. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM (2010) Reduced posterior cingulated mitochondrial activity in expired young adult carriers of the APOE -4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis 22, 307-313.
33. Frick KM, Baxter MG, Markowska AL, Olton DS, Price DL (1995) Age-related spatial reference and working memory deficits assessed in the water maze. Neurobiol Aging 16, 149-160.
34. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm AC (2006) Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci 24, 229-242.
35. Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
36. Valla J, Schneider L, Small A, Gonzalez-Lima F (2007) Quantitative cytochrome oxidase histochemistry: Applications in human Alzheimer's disease and animal models. J Histotechnol 30, 235-247.
37. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, Academic Press, San Diego.
38. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3, 27.
39. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) IntraneuronalA-causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
40. Hirata-Fukae C, Li H, Hoe H, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, RebeckGW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216, 92-103.
41. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activiating SIRT1 and PGC-1-. Cell 127, 1109-1122.
42. Schmidt-Wilcke T, Poljansky S, Hierlmeier S, Hausner J, Ibach B (2009) Memory performance correlates with gray matter density in the ento-/perirhinal cortex and posterior hippocampus in patients with mild cognitive impairment and healthy controls: A voxel based morphometry study. NeuroImage 47, 1914-1920.
43. Braden BB, Talboom JS, Crain ID, Simard AR, Lukas RJ, Prokai L, Scheldrup MR, Bowman BL, Bimonte-Nelson HA (2010) Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats. Neurobiol Learn Mem 93, 444-453.
44. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27, 13357-13365.
45. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in -amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure. Brain Res 1366, 233-245.
46. Lee DC, Rizer J, Selenica ML, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D (2010) LPSinduced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 7, 56.